The following information is based on a press release from Q-Med AB (Q-Med) dated December 13, 2010 and may be subject to change.
Galderma Holding AB (Galderma) has on December 13, 2010, announced a public takeover offer to the shareholders of Q-Med whereby every one (1) Q-med share held entitles their holder to a cash payment of SEK 75.00. If Q-Med, as a result of the offer, requests for a de-listing of the underlying share or if the trading in the same is considered to be insufficient to support related derivatives trading, NASDAQ OMX Derivatives Markets will (1) set a new expiration day for options and forward contracts in Q-Med and (2) settle the contracts at Fair Value.
For further information, please see the attached file.
